Antiepileptics for aggression and associated impulsivity

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2008, Pages

  Huband, Nick ^a   Ferriter, Michael ^a   Nathan, Rajan ^b   Jones, Hannah ^a  

^a NOTTINGHAMSHIRE HEALTHCARE NHS TRUST   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ETHOSUXIMIDE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PIRACETAM; PLACEBO; PREGABALIN; PRIMIDONE; TIAGABINE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

AGGRESSION; ANGER; ATTENTION DEFICIT DISORDER; BRIEF PSYCHIATRIC RATING SCALE; CLINICAL TRIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFICACY; HOSTILITY; HUMAN; IMPULSIVENESS; LEARNING DISORDER; PERSONALITY DISORDER; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW;

EID: 55049098345     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003499.pub2     Document Type: Review

References (49)

1. Altman 1996 Altman DG, Bland JM. Detecting skewedness from summary information. British Medical Journal 1996;313(7066):1200.
2. American Psychiatric Association 2000 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington DC: American Psychiatric Association, 2000.
3. Anderson 1999 Anderson SW, Bechara A, Damasio H, Tranel D, Damasio AR. Impairment of social and moral behavior related to early damage in the human prefrontal cortex. Nature Neuroscience 1999;2:1032-7.
4. Arseneault 2000 Arseneault L, Moffitt TE, Caspi A, Taylor PJ, Silva PA. Mental disorders and violence in a total birth cohort. Results from the Dunedin Study. Archives of General Psychiatry 2000;57:979-86.
5. Attkisson 1982 Attkisson CC, Zwick R. The client satisfaction questionnaire. Psychometric properties and correlations with service utilization and psychotherapy outcome. Evaluation and Program Planning 1982;5:233-7.
6. Barratt 1997 Barratt ES, Stanford MS, Felthous AR, Kent TA. The effects of phenytoin on impulsive and premeditated aggression: a controlled study. Journal of Clinical Psychopharmacology 1997;17(5):341-9.
7. Barratt 1999 Barratt ES, Stanford MS, Dowdy L, Liebman MJ, Kent TA. Impulsive and premeditated aggression: a factor analysis of self-reported acts. Psychiatry Research 1999;86(2):163-73.
8. Berkowitz 1993 Berkowitz L. Aggression: Its causes, consequences and control. Philadelphia PA: Temple University Press, 1993.
9. Brennan 2000 Brennan PA, Mednick SA, Hodgins S. Major mental disorders and criminal violence in a Danish birth cohort. Archives of General Psychiatry 2000;57(5):494-500.
10. Buss 1992 Buss AH, Perry M. The Aggression Questionnaire. Journal of Personality and Social Psychology 1992;63:452-9.
11. Coccaro 1991 Coccaro EF, Harvey PH, Kupshaw-Lawrence E, Herbert JL, Bernstein DP. Development of neuropharmacologically based behavioral assessments of impulsive aggressive behavior. Journal of Neuropsychiatry and Clinical Neurosciences 1991;3 (Suppl):44-51.
12. Connor 1996 Connor DF, Steingard RJ. A clinical approach to the pharmacotherapy of aggression in children and adolescents. Annals of the New York Academy of Sciences 1996;794:290-307.
13. Derogartis 1973 Derogartis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale; preliminary report. Psychopharmacology Bulletin 1973;9:13-28.
14. Donner 2001 Donner A, Piaggio G, Villar J. Statistical methods for the meta-analysis of cluster randomized trials. Statistical Methods in Medical Research 2001;10:325-38.
15. Egger 1997 Egger M, Davey-Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 1997;315:629-34.
16. Elbourne 2002 Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140-9.
17. EuroQoL group 1990 EuroQoL Group. EuroQoL: a new facility for measurement of health-related quality of life. Health Policy 1990;16:199-208.
18. Fazel 2006 Fazel S, Grann M. The population impact of severe mental illness on violent crime. American Journal of Psychiatry 2006;163(8):1397-403.
19. Follmann 1992 Follmann D, Elliot P, Suh I, Cutler J. Variance imputation for overviews of clinical trials with continuous response. Journal of Clinical Epidemiology 1992;45(7):769-73.
20. Gamble 2005 Gamble C, Hollis S. Uncertainty method improved on best-worst case analysis in a binary meta-analysis. Journal of Clinical Epidemiology 2005;58:579-88.
21. Gardner 1986 Gardner DL, Cowdry RW. Positive effects of carbamazepine on behavioral dyscontrol in borderline personality disorder. American Journal of Psychiatry 1986;143(4):519-22.
22. Gobbi 2006 Gobbi, G, Gaudreau P, Leblanc N. Efficacy of topiramate, valproate and their combination on aggression/agitation behaviour in patients with psychosis. Journal of Clinical Psychopharmacology 2006;26(5):467-73.
23. Goedhard 2006 Goedhard LE, Stolker JJ, Heerdink ER, Nijman HL, Olivier B, Egberts TC. Pharmacotherapy for the treatment of aggressive behavior in general adult psychiatry: A systematic review. Journal of Clinical Psychiatry 2006;67(7):1013-24.
24. Haller 2006 Haller J, Kruk MR. Normal and abnormal aggression: human disorders and novel laboratory models. Neuroscience and Biobehavioral Reviews 2006;30(3):292-303.
25. Hawkins 2000 Hawkins KA, Tobst KK. Frontal lobe dysfunction and aggression: conceptual issues and research findings. Aggressive and Violent Behavior 2000;5(2):147-57.
26. Higgins 2008 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 5.0.0. www.cochrane.org/resources/handbook/ hbook.htm 2008; Vol. (accessed 1 April 2008).
27. Hollander 2003 Hollander E, Tracy KA, Swann AC, Coccaro EF, McElroy SL, Wozniak P, et al.Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders. Neuropsychopharmacology 2003;28(6):1186-97.
28. Hollander 2005 Hollander E, Swann AC, Coccaro EF, Jiang P, Smith TB. Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder. American Journal of Psychiatry 2005;162(3):621-4.
29. Kanemoto 1999 Kanemoto K, Kawasaki J, Mori E. Violence and epilepsy: a close relation between violence and postictal psychosis. Epilepsia 1999;40(1):107-9.
30. Kavoussi 1989 Kavoussi RJ, Coccaro EF. Divalproex sodium for impulsive aggressive behavior in patients with personality disorder. Journal of Clinical Psychiatry 1989;59(12):676-80.
31. Kay 1989 Kay SR, Opler LA, Lindenmayer JP. The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. British Journal of Psychiatry 1989;155 (Suppl):59-65.
32. Keele 2005 Keele NB. The role of serotonin in impulsive and aggressive behaviors associated with epilepsy-like neuronal hyperexcitability in the amygdala. Epilepsy and Behavior 2005;73(3):325-35.
33. Kessler 2006 Kessler R, Coccaro E, Fava M, Jaeger S, Jin R, Walters E. The prevalence and correlates of DSM-IV intermittent explosive disorder in the National Comorbidity Survey replication. Archives of General Psychiatry 2006;63(6):669-78.
34. Malone 1994 Malone RP, Luebbert RP, Pena-Ariet M, Biesecker K, Delaney MA. The Overt Aggression Scale in the study of lithium in aggressive conduct disorder. Psychopharmacology Bulletin 1994;30:215-8.
35. Miczek 2002 Miczek KA, Fish EW, De Bold JF, De Almeida RM. Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems. Psychopharmacology (Berl). 2002;163(3-4):434-58.
36. Nelson 2007 Nelson RJ, Trainor BC. Neural mechanisms of aggression. Nature Reviews Neuroscience 2007;8(7):536-46.
37. Nestor 2002 Nestor PG. Mental disorder and violence: personality dimensions and clinical features. American Journal of Psychiatry 2002;159(12):1973-8.
38. Patton 1995 Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt impulsiveness scale. Journal of Clinical Psychology 1995;51(6):768-74.
39. Siever 2008 Siever LJ. Neurobiology of aggression and violence. American Journal of Psychiatry 2008;165(4):429-42.
40. Spielberger 1999 Spielberger CD. STAXI-2: State-Trait Anger Expression Inventory-2. Odessa, FL: Psychological Assessment Resources, Inc., 1999.
41. Staller 2007 Staller JA. Psychopharmacologic treatment of aggressive preschoolers: a chart review. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2007;31(1):131-5.
42. Stanford 2001 Stanford MS, Houston RJ, Mathias CW, Greve KW, Villemarette-Pittman NR, Adams D. A double-blind placebo-controlled crossover study of phenytoin in individuals with impulsive aggression. Psychiatry Research 2001;103(2-3):193-203.
43. Stein 1992 Stein G. Drug treatment of the personality disorders. British Journal of Psychiatry 1992;161:167-82.
44. Tritt 2005 Tritt K, Nickel C, Lahmann C, Leiberich PK, Rother WK, Loew TH, et al.Lamotrigine treatment of aggression in female borderline-patients: a randomized, double-blind, placebo-controlled study. Journal of Psychopharmacology 2005;19(3):287-91.
45. Tyrer 1988 Tyrer P, Seivewright N. Pharmacological treatment of personality disorders. Clinical Neuropharmacology 1988;11(6):493- 9.
46. van Elst 2000 van Elst LT, Woermann FG, Lemieux L, Thompson PJ, Trimble MR. Affective aggression in patients with temporal lobe epilepsy: a quantitative MRI study of the amygdala. Brain 2000;123(2):234-43.
47. Vitiello 1997 Vitiello B, Stoff DM. Subtypes of aggression and their relevance to child psychiatry. American Academy of Child and Adolescent Psychiatry 1997;36(3):307-15.
48. World Health Organization 1993 World Health Organization. The ICD-10 Classification of Mental and Behavioral Disease. Geneva: World Health Organization, 1993.
49. World Health Organization 2002 World Health Organization. World Report on Violence and Health. Geneva: World Health Organization, 2002.